Clin2
NCT07511660Possibly a fitEnrolling by invitation

Ovarian cell injection for perimenopause symptom relief

PerimenopausePerimenopause-Related DepressionPremature Ovarian InsufficiencyPremature Ovarian Failure (POF)Premature Ovarian FailureMenopauseMenopause Hot FlashesMenopause Ovarian Failure

Part of Cancer, Genetic & congenital, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This trial tests injecting special cells called Muse cells into the ovaries to help relieve perimenopause symptoms and possibly restore ovarian function. It may help women experiencing irregular periods, hot flashes, sleep problems, mood changes, or trouble thinking clearly.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
12 people
Ages
28 years to 70 years
Study type
Observational

Who can take part

  • You are a woman between 28 and 70 years old.
  • You are in perimenopause, meaning you have irregular periods, high FSH levels, low AMH levels, or symptoms like hot flashes or mood changes.
  • You are willing to get an injection of Muse cells into your ovary guided by ultrasound.
  • You can make all follow-up visits for 2 years and complete blood tests, ultrasounds, and questionnaires.
  • You are healthy enough for a minor procedure done under sedation or local anesthesia.
  • You have not used hormone therapy in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07775391Recruiting· Phase 1/Phase 2
Stem cell infusion for early menopause

This trial tests whether a single infusion of stem cells made from human umbilical cord tissue can help women with premature ovarian insufficiency (early menopause) by improving ovarian function and reducing menopause symptoms. Participants will continue their usual hormone replacement therapy during the study.

Beijing, Beijing Municipality
NCT06302543Recruiting
Bone Marrow Cells for Early Menopause

This trial tests whether injecting your own bone marrow cells can help reverse early menopause (premature ovarian insufficiency). It's for people who have not responded to standard hormone therapy.

Baghdad
NCT03916978Recruiting· Phase 2/Phase 3
PRP treatment to help restore ovarian function in menopause

This trial tests whether injecting your own PRP (platelet-rich plasma) into the ovaries can improve ovarian function in some menopausal women. It may help those whose menopause seems less advanced, but not everyone will be eligible based on health and test results.

Athens
NCT07115082Recruiting· Phase 1/Phase 2
Stem cells from amniotic fluid for early menopause

This study tests whether stem cells from the fluid around a baby (amniotic membrane) can help women with premature ovarian insufficiency improve their chances of getting pregnant. It is designed for women under 40 who have not had a period for months and have high FSH levels.

Shanghai
NCT04031456Recruiting· Phase 2/Phase 3
PRP treatment to help ovaries work again in early ovarian failure

This trial studies whether an injection of your own PRP (platelet-rich plasma) can improve how your ovaries work in people with early ovarian failure. If it helps, it may lead to better hormone balance and return of more regular ovulation and periods.

Athens
NCT07117682Not yet recruiting
Stem cell injection for low ovarian reserve

This trial tests whether injecting your own fat-derived stem cells (ADRCs) can improve ovarian function in women with diminished ovarian reserve (DOR). Doctors will take a small amount of fat from you, process it to get stem cells, and inject those cells back into your ovaries.

Hear when a new Perimenopause trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.